Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  News

News

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesHot NewsMost Read NewsRecomm.Business LeadersCalendar 

U.S. Stocks Rally; DJIA Tops 14000

share with twitter share with LinkedIn share with facebook
share via e-mail
0
02/01/2013 | 01:15pm CEST

By MATT JARZEMSKY

--U.S. stocks rally as late-2012 payrolls revised higher

--January job growth, unemployment rate miss views

--Factory-activity data show bigger-than-expected expansion

NEW YORK--Fresh off a blowout January, stocks started February with a bang.

The Dow industrials topped 14000 for the first time since 2007, capping their fifth-straight weekly gain, following encouraging data on U.S. jobs and manufacturing.

The Dow Jones Industrial Average advanced 149.21 points, or 1.1%, to 14009.79 Friday, climbing above 14000 for the first time since Oct. 12, 2007.

"Psychologically, it's a monumental number," said Daniel Morgan, senior portfolio manager at Synovus Trust, which manages $3.9 billion. "It happened quicker than a lot of people thought it might, based on what's going on with the economy and the political climate."

The Standard & Poor's 500-stock index rose 15.06 points, or 1%, to 1513.17, a day after capping a 5% monthly gain, the biggest since October 2011. Telecommunications shares in the S&P 500 led gains across all 10 of the index's sectors. The Nasdaq Composite Index climbed 36.97 points, or 1.2%, to 3179.10.

U.S. employers added 157,000 jobs in January, the Labor Department reported, falling short of the 166,000 new payrolls predicted by economists in a Dow Jones Newswires poll. But the department said the economy added an average of 181,000 jobs a month last year, better than the 153,000 pace originally reported, as it revised initial readings for November and December higher.

"Those revision numbers for the last couple months were really nice," said Colleen Supran, a San Francisco principal at Bingham, Osborn & Scarborough LLC, which manages $2.5 billion. "We certainly are encouraged by the steady stream of somewhat good news, though the recovery has been uneven and probably will continue to be somewhat uncertain going forward."

Last month's unemployment rate, obtained in a separate survey of U.S. households, edged up to 7.9% from 7.8% in December. Economists had predicted it would remain unchanged. Average hourly earnings rose 0.2%, in line with economists' views.

Elsewhere on the economic front, the Institute for Supply Management's January manufacturing purchasing managers' index, a measure of factory activity, rose more than economists had expected. A preliminary reading of the Thomson-Reuters and University of Michigan consumer-sentiment index for January also rose more than expected. Construction spending for December increased.

European markets were mostly higher, with the Stoxx Europe 600 up 0.3%, after Markit's euro-zone purchasing managers' index contracted at the slowest rate in 11 months. Spanish stocks bucked the trend by selling off after a ban on short selling, or betting against shares, was lifted. The IBEX 35 index dropped 1.6%.

Asian markets were broadly higher on the back of strong Chinese manufacturing data and further weakness in the yen. China's Shanghai Composite Index climbed 1.4% after HSBC's January purchasing managers' index rose to a two-year high. The index climbed 5.6% on the week. Japan's Nikkei Stock Average gained 0.5% to finish at a 52-week high, up 2.4% for the week.

Crude-oil prices rose 0.3%, to settle at $97.77 a barrel, while gold gained 0.5%, to settle at $1,669.40 a troy ounce. The dollar rallied versus the yen but weakened against the euro. The 10-year Treasury note fell in price, pushing its yield up to 2.017%.

In the corporate arena, Merck slipped 3.3% after the blue-chip drug maker's fourth-quarter profit slumped. Last year's loss of patent protection for asthma treatment Singulair continued to pressure sales.

Zoetis, the world's largest animal-medicine company by revenue, rallied 19% on its first day of trading on the New York Stock Exchange. The company's initial public offering, in which it separated from drug company Pfizer, was the largest U.S. debut for a U.S. company since Facebook in May.

Perrigo, the store-brand pharmaceutical- and nutritional-products maker, rose 4.7% after reporting better-than-expected quarterly revenue.

Tyson Foods climbed 3.1% after the meat processor beat earnings estimates, offsetting a slight miss in revenue, as operating margin increased and interest costs fell.

Life Time Fitness slid 22% after the company indicated fourth-quarter earnings and revenue would fall short of expectations, citing lower membership growth and higher costs to draw in new customers.

McKesson dropped 1.9% after the medical-products distributor's fiscal third-quarter earnings missed forecasts and the company trimmed its full-year outlook.

Alkermes declined 5.6% after Ireland-based biotechnology company Elan said it sold all of its remaining stake in the biopharmaceutical company.

Audience surged 15% after the smartphone audio-processing-technology company reported better-than-expected fourth-quarter earnings and said it expects to report a profit for the current quarter. Analysts had projected a loss.

Google rose 2.6% to $775.60, an all-time closing high.

Write to Matt Jarzemsky at matthew.jarzemsky@dowjones.com

Subscribe to WSJ: http://online.wsj.com?mod=djnwires

share with twitter share with LinkedIn share with facebook
share via e-mail
0
React to this article
Latest news
Date Title
10:30p GREENS EUROPEAN FREE ALLIANCE IN EUROPEA : Glyphosate approval - EU governments should begin glyphosate phase-out following Commission intransigence
10:30p PRESS RELEASE : IMF Reaches Staff-Level Agreement for Completion of Eighth Review of Albania’s Extended Arrangement
10:30p TOM COTTON : Cotton Announces 2016 U.S. Service Academy Appointees
10:30p FISHER & PAYKEL HEALTHCARE : DRP strike price and AUD FX rate for final dividend
10:30p ROB PORTMAN : Portman and Brown Urge Action to Protect Pensions of Ohio Miners
10:30p Brower Piven Commences An Investigation Into The Proposed Sale Of American Science and Engineering, Inc. And Encourages Shareholders To Contact The Firm For Additional Information
10:30p ASSURANT : Executives Named 2016 Women Worth Watching
10:30p GOLD RESOURCE CORPORATION : Declares June Monthly Dividend
10:30p FREDDIE MAC : Issues Monthly Volume Summary for May 2016
10:30p THE NEW IRELAND FUND, INC. : Announces Potential Tender Offer
Latest news
Advertisement
Hot News 
CARPETRIGHT : Annual Profit Up But Cautious On Outlook After Brexit Vote
XENCOR : Announces Strategic Collaboration for Bispecific Programs, including XmAb 14045 and XmAb 13676
CELYAD : Announces Results for the CHART-1 Phase III Clinical Trial Evaluating C-Cure® Cell Therapy
Pomerantz Law Firm Investigates Claims On Behalf of Investors of Regulus Therapeutics Inc. - RGLS
BABCOCK & WILCOX ENTERPRISES, INC. : Costs Associated with Exit or Disposal Activities, Material Impairments, Financial Statements and Exhibits (form 8-K)
Most Read News
06/27 Global equities sell off for second day, safe-havens up in Brexit aftermath
04:06aDJU.S. Stocks Rise After Brexit Rout
04:46a MAZDA MOTOR : Japan eyes help for small business in stimulus plan after Brexit
01:57p VW agrees to buy back diesel vehicles, fund clean air efforts
Most recommended articles
04:29p IMPORTANT TO LOOK AT INDIVIDUALS IN VW SCANDAL : Lynch
04:26pDJGlobal Markets Steady After Brexit-Related Rout
04:26pDJCA : Sam Wyly Gets a $1.1 Billion Tax Bill
04:20p NIKE : quarterly sales rise less than expected
04:10p TSX rises as oil rallies, investors seek bargains after Brexit